Sunday, September 25, 2016 11:55:44 AM
My recollection, which again could be wrong, is that GALT's other drug (GM-CT-01-I think that's the name) was a previous generation, and the GR-MD-02 is 2nd gen from that. However, I think the entire platform was based on the drug that La Jolla Pharm. was testing for kidney fibrosis (I believe that trial series was stopped or suspended due to the FDA requiring more info. and also La Jolla's re-positioning of funds).
Phase1 and Phase2 drug are the same "GR-MD-02"
I think a lot of this stuff might be found in this forum if you go bac far enough.
Phase1 and Phase2 drug are the same "GR-MD-02"
I think a lot of this stuff might be found in this forum if you go bac far enough.
Recent GALT News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/13/2026 04:15:21 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/31/2026 08:11:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 11:55:24 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 11:50:49 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 01:46:55 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 01:46:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 11:50:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2026 09:25:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2026 10:01:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:50:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:50:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:49:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:49:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:48:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:47:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:46:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:46:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:45:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:44:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 09:44:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 01:40:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 10:00:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:54:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:53:32 PM
